Why Afro Hair Transplants Fail, and the Tests to Ask For First

On the public hair-restoration forums there is a pattern that repeats for Afro-textured hair, and it is worth reading before you book anything: work done on the edges or temples, growth for four or five months, then loss again between eight and twelve — and in every case we could find, no biopsy before surgery. This page is about the tests that would have caught it.

The failure the forums keep recording

Three cases, paraphrased from public threads and with nobody named. A woman in the UK, told she had traction alopecia, had close to three thousand grafts placed by strip; the hair grew to month five, then miniaturised over the following months without ever shedding, and back she went to where she started. Nobody had biopsied her before the operation; the loss had actually followed a chemical relaxer, and the experienced posters who read her thread thought the diagnosis was wrong. A man had thirteen hundred grafts to lower his hairline and at two years reported it “still the same”, with a bumpy, scarred hairline. A young woman with 4C hair asking which surgeon to choose for her edges was told, before anything else, to get a biopsy to confirm it really was traction.

Those are not surgical failures in the ordinary sense. They are the right operation done on the wrong diagnosis. And the diagnosis is where the published evidence says the difficulty actually lives.

Why: the edge is where diagnoses go wrong

In a review of 15 patients with scarring alopecia of the scalp margin, six gave a history of relaxing or straightening their hair, six denied hair care practices sufficient to cause traction alopecia, and in three the history was unknown. The author reports that scarring at the margin is difficult to diagnose both clinically and histologically, and that the absence of a history of severe traction in half the patients casts doubt on whether traction is the only cause.^[1]

Read the second half of that again: difficult to diagnose both clinically and histologically. A receded, shiny margin looks like traction alopecia. It can also be frontal fibrosing alopecia, or a patchy form of CCCA, or the late stage of traction that has become scarring — and those change what surgery can be asked to do, because grafts placed into an active scarring process are placed into the thing that destroys follicles.

There is one clinical clue that helps. In the series that named the fringe sign, 35 of 41 women with traction alopecia had a retained strip of hairs along the frontal or temporal rim, and every woman whose traction involved the marginal hairline had one. A later review describes the preservation of that fringe as a clue that distinguishes traction alopecia from frontal fibrosing alopecia, where it is lost.^[2,3]

If your rim of edges is still there, that points towards traction. If it is gone, it is a reason to look harder before anybody operates. We wrote about what happens to that rim after surgery on its own page.

Test one: a biopsy, before anyone touches your edges

A review of traction alopecia states that histopathology can distinguish traction alopecia from alopecia areata, frontal fibrosing alopecia and patchy central centrifugal cicatricial alopecia, and that dermoscopy can detect ongoing traction through the presence of hair casts.^[1,3]

That is what a biopsy is for: telling the conditions apart. It is a small punch of skin from the active edge of the loss, not from the bald centre, read by a pathologist who knows hair. For a hairline or temple transplant in Afro-textured hair we think it should be routine, and in the three forum cases above it was not done.

Test two: a test session

In the two published CCCA transplant cases, both patients had a scalp biopsy and a hair transplant test session before the full procedure, and hair growth at the recipient sites was first observed between four and five months after the test session.^[5]

A test session means placing a small number of grafts — clinics that do this describe ten to twenty, though that figure is practice rather than published — and waiting to see whether they grow before committing the donor area to thousands. In scarred or previously inflamed skin it is the closest thing to a rehearsal that exists. It costs a few months. The alternative, in the forum cases, cost the donor area.

Test three: is the disease quiet, and how does anyone know?

Hair transplantation has been reported as safe and effective in CCCA, but only in two published cases, and only where the disease was end-stage and a scalp biopsy showed no remaining inflammation.^[5]

Here the evidence runs out, and says so itself. The authors of the systematic review state that they were unable to find evidence on how to precisely diagnose disease activity, or on when after disease activity it is appropriate to perform surgery. They also state that the commonly suggested two-year rule for hair transplant surgery after disease activity was not substantiated in their review.^[6]

Since that review there is at least an instrument for CCCA. A scoring tool for CCCA disease activity was published in 2025. The C-CAT scores five things from 0 to 2 each: pain, itching, redness, scalp resistance and disease progression. In the 82 patients it was developed on, all of them African-American and 98 percent women, the average score at the first visit was 3.3; after treatment 88 percent improved and 48 percent reached a score of zero, which the tool defines as remission, over an average of 195 days.^[7] It was built to track treatment, not to clear anyone for surgery, and it says nothing about transplants — but a score of zero on it, held for months, is a concrete thing to ask for. How long the disease should have been quiet is not settled anywhere: shedding or a flare goes through what is and is not known.

The curve nobody shows you

A systematic review of hair transplantation in primary cicatricial alopecia, covering eight observational studies and 123 patients, reported weighted graft survival of 82.7 percent at 7 to 12 months, 73.3 percent at 13 to 24 months, 58.4 percent at 25 to 36 months, 55.4 percent at 37 to 48 months and 39.6 percent at 49 to 72 months, concluding that survival peaks at one year and diminishes over time.^[4,8]

In the same review, four of the 123 patients developed reactivation of their scarring disease after the transplant.^[4,8]

How that curve compares with the counted series in pattern hair loss, and why nobody has drawn one for Afro-textured hair, is on how long a hair transplant lasts.

That is primary cicatricial alopecia — lichen planopilaris, frontal fibrosing alopecia, CCCA and their relatives. Traction alopecia is not in that group and this curve is not yours if traction is truly what you have. It is on this page for the opposite reason: it is what happens when it is not truly what you have. A hairline that grows at month five and is gone at month twelve is not a mystery inside that curve. It is the curve.

If it has already happened: what the pattern of loss tells you

These are questions to take to a dermatologist, not a diagnosis. What is sourced is marked; the rest is how experienced surgeons reason about it in public.

• Nothing grew, anywhere. The question is whether the scalp was scarring. A biopsy now is the sourced step; the fringe, if it survived, is the clinical clue.
• It grew, then thinned from month eight onwards, without a shedding phase. This is the forum pattern and it is the shape of the curve above. Reactivation of a scarring process is the thing to exclude first.
• Patches, especially at the back. Patchy hair loss in the donor area after follicular unit extraction can resemble alopecia areata both clinically and on trichoscopy, where black dots, exclamation-mark hairs and the coudability sign were all present. On biopsy the picture was different: dilated capillaries around the follicles, mucin deposition around the arrector muscles, dermal oedema and only a few lymphocytes, resembling a healing wound. The authors conclude that it should not be confused with alopecia areata.^[9]
• Patchy growth at the front. Surgeons discuss transection, folliculitis and deep placement as causes. Ask what the grafts looked like under the microscope on the day — if nobody looked, that is an answer too.

Shedding of your own hair in the weeks after surgery is a different thing again, usually temporary, and covered on the shock loss page.

What we will not tell you

• That a biopsy makes surgery safe. It makes the diagnosis more likely to be right.
• That a test session predicts the full result. It rules out the worst case; it does not promise the best.
• A number of quiet months after which it is safe to operate. Nobody has established one.
• Which of the three forum cases you resemble. That is what the biopsy is for.

What to ask before you book — here or anywhere

1. Will you biopsy the active edge before surgery, and who reads it? If the answer is that it is unnecessary for traction alopecia, ask how they ruled out the conditions that look like it.
2. Do you do a test session first? And how many months before you judge it?
3. How do you decide the disease is quiet? A named instrument, a period, photographs — or a feeling. The honest answer may be that nobody knows; you want a surgeon who says so.
4. What happens if it fails, and what will it cost me? A plan, not reassurance.
5. Am I even a candidate? The six questions on our before you book page come first.

We publish how we would answer each of these in our own measurement protocol, including the part where we say what we do not know. If you want them answered about your own scalp, send them to us.